MEDIROM Healthcare Technologies Inc. 在日本提供全面的医疗保健服务。该公司总部位于日本东京。
财务指标
营业收入
2026-03-31
$6.11亿
2025-12-31
$6.11亿
2025-09-30
$31.52亿
2025-03-31
$48.23亿
营业支出
2026-03-31
$5.39亿
2025-12-31
$5.39亿
2025-09-30
$11.56亿
2025-03-31
$10.51亿
净利润
2026-03-31
$6342.78万
2025-12-31
$6342.78万
2025-09-30
-$6.71亿
2025-03-31
$7.3亿
净利润率
2026-03-31
10.36%
2025-12-31
10.36%
2025-09-30
-21.28%
2025-03-31
15.15%
每股收益
2026-03-31
--
2025-12-31
--
2025-09-30
$-87.38
2025-03-31
$110.27
息税折旧摊销前利润
2026-03-31
$8337.14万
2025-12-31
$8337.14万
2025-09-30
-$5.69亿
2025-03-31
$8.28亿
有效税率
2026-03-31
1.26%
2025-12-31
1.26%
2025-09-30
-0.01%
2025-03-31
-14.87%
项目
2026-03-31
2025-12-31
2025-09-30
2025-03-31
营业收入
$6.11亿
$6.11亿
$31.52亿
$48.23亿
营业支出
$5.39亿
$5.39亿
$11.56亿
$10.51亿
净利润
$6342.78万
$6342.78万
-$6.71亿
$7.3亿
净利润率
10.36%
10.36%
-21.28%
15.15%
每股收益
--
--
$-87.38
$110.27
息税折旧摊销前利润
$8337.14万
$8337.14万
-$5.69亿
$8.28亿
有效税率
1.26%
1.26%
-0.01%
-14.87%
常见问题
MRM is a publicly traded equity identified by its ticker symbol on a U.S. stock exchange. It represents a fractional ownership stake in the underlying company, giving shareholders a claim on residual earnings and assets. The stock's price reflects market expectations about that company's future performance and risk. For the exact corporate name, exchange, and business description tied to MRM, refer to the latest company profile data shown on this page.
MRM's price can be influenced by company-specific developments such as earnings results, management guidance, capital allocation decisions, and operational updates. Broader forces also matter, including sector trends, interest rates, inflation, and overall market sentiment. Supply and demand for the shares, liquidity, and investor positioning can amplify price moves. Reviewing timely news and MRM's financial disclosures can help investors understand which factors are currently driving the stock.
Valuation is typically assessed using multiples like price-to-earnings, price-to-sales, price-to-book, and enterprise value-to-EBITDA, along with growth and margin trends. Comparing MRM's multiples with its own history and with peer companies provides context. A single metric rarely tells the full story, so combining several measures and considering the quality of earnings is useful. Current valuation metrics for MRM appear in the data on this page.
MRM shares can generally be bought or sold in pre-market and after-hours sessions through many brokers, though liquidity is often thinner and spreads wider than during the regular trading day. Extended-hours trading carries additional risks, including larger price swings and reduced order depth. Availability depends on the broker and the exchange. For MRM's regular session hours and any applicable details, check the trading information displayed on this page.
Start with MRM's income statement, balance sheet, and cash flow statement to assess revenue growth, profitability, leverage, and cash generation. Key metrics include gross and operating margins, earnings per share, free cash flow, and return on equity. Comparing these figures across several periods and against industry peers helps identify trends. Up-to-date financial statements and reported results for MRM are available through the data on this page.
Risks for MRM include company-specific challenges such as competitive pressure, execution issues, customer concentration, or balance-sheet stress, as well as broader market and economic risks. Sector disruptions, regulatory changes, and interest-rate shifts can also affect performance. Liquidity and volatility may magnify losses in adverse conditions. Reviewing MRM's risk disclosures and the latest financial reports helps investors understand which risks are most relevant.